A detailed history of Krilogy Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Krilogy Financial LLC holds 11,107 shares of ABBV stock, worth $2 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
11,107
Previous 11,161 0.48%
Holding current value
$2 Million
Previous $1.91 Million 14.58%
% of portfolio
0.16%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $8,847 - $10,763
-54 Reduced 0.48%
11,107 $2.19 Million
Q2 2024

Jul 22, 2024

SELL
$154.79 - $180.76 $17,181 - $20,064
-111 Reduced 0.98%
11,161 $1.91 Million
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $59,293 - $67,559
371 Added 3.4%
11,272 $2.05 Million
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $1.5 Million - $1.69 Million
10,901 New
10,901 $1.69 Million
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $774,675 - $892,154
-5,357 Reduced 34.8%
10,038 $1.6 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $990,852 - $1.19 Million
7,164 Added 87.04%
15,395 $2.49 Million
Q3 2022

Oct 06, 2022

BUY
$134.21 - $153.93 $50,194 - $57,569
374 Added 4.76%
8,231 $1.11 Million
Q2 2022

Jul 14, 2022

BUY
$137.62 - $174.96 $32,203 - $40,940
234 Added 3.07%
7,857 $1.2 Million
Q1 2022

Apr 28, 2022

BUY
$131.98 - $163.75 $352,914 - $437,867
2,674 Added 54.03%
7,623 $1.24 Million
Q4 2021

Jan 27, 2022

BUY
$107.43 - $135.93 $15,255 - $19,302
142 Added 2.95%
4,949 $670,000
Q3 2021

Oct 25, 2021

BUY
$106.4 - $120.78 $27,132 - $30,798
255 Added 5.6%
4,807 $519,000
Q2 2021

Jul 20, 2021

SELL
$105.21 - $117.21 $44,819 - $49,931
-426 Reduced 8.56%
4,552 $513,000
Q1 2021

Apr 21, 2021

BUY
$102.3 - $112.62 $30,894 - $34,011
302 Added 6.46%
4,978 $539,000
Q4 2020

Feb 11, 2021

SELL
$80.49 - $108.67 $13,441 - $18,147
-167 Reduced 3.45%
4,676 $501,000
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $79,209 - $92,965
922 Added 23.51%
4,843 $424,000
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $31,035 - $41,530
423 Added 12.09%
3,921 $384,000
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $1,612 - $2,444
-25 Reduced 0.71%
3,498 $266,000
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $254,113 - $317,950
3,523 New
3,523 $311,000
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $226,476 - $272,289
-3,596 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $20,301 - $25,949
309 Added 9.4%
3,596 $262,000
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $13,345 - $15,706
173 Added 5.56%
3,287 $265,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $70,142 - $86,505
-901 Reduced 22.44%
3,114 $287,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $5,512 - $6,128
-62 Reduced 1.52%
4,015 $380,000
Q2 2018

Aug 15, 2018

BUY
$89.78 - $106.23 $95,346 - $112,816
1,062 Added 35.22%
4,077 $378,000
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $19,138 - $25,627
-208 Reduced 6.45%
3,015 $285,000
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $16,389 - $17,972
-183 Reduced 5.37%
3,223 $312,000
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $23,679 - $30,245
339 Added 11.05%
3,406 $303,000
Q2 2017

Aug 15, 2017

BUY
N/A
3,067
3,067 $222,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.